| Issue Date | Title | Author(s) |
41 | 2007 | Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells | Baran, Yusuf ; Ural, Ali Uğur; Gündüz, Ufuk |
42 | 2015 | Mesenchymal stem cells administered intraperitoneally have a potent effects on the experimental allergic airway disease | Işık, S.; Adan, Aysun ; Karaman, M.; Kiray, M.; Bağrıyanık, H. A.; Çağlayan-Sözmen, S.; Uzuner, N.; Baran, Yusuf |
43 | 2015 | The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin | Adan Gökbulut, Aysun ; Baran, Yusuf |
44 | 2023 | MicroRNAs and long non-coding RNAs as novel targets in anti-cancer drug development | Çetinkaya, Melisa; Baran, Yusuf |
45 | 2012 | A natural product, quercetin enhances the cytotoxic and apoptotic effects of dexamethasone on jurkat cells | Baran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur |
46 | 2009 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells, as effectively as in parental sensitive counterparts | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan |
47 | 2012 | A novel agent, KL-21, has significant anticancer potential on chronic lymphocytic leukemia cells but not on healthy cells | Baran, Yusuf ; Gökbulut, Aysun ; Yaşar, M. |
48 | 2010 | A novel mechanism of nilotinib-induced apoptosis; bioactive sphingolipids | Baran, Yusuf ; Camgöz, Aylin; Gençer, Emel; Ural, Ali; Avcu, Ferit |
49 | 2013 | Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells | Avcı, Çığır Biray; Kayabaşı, Çağla; Yılmaz Süslüer, Sunde; Balcı, Tuğçe; Saydam, Güray; Baran, Yusuf ; Gündüz, Cumhur |
50 | 2012 | Quercetin induced apoptosis in 232B4 chronic lymphocytic leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Apohan, Elif; Pişkin, Özden; Özcan, Mehmet Ali |
51 | 2022 | The role of miRNA in cancer: Pathogenesis, diagnosis, and treatment | Uzuner, Erez; Ulu, Gizem Tuğçe ; Gürler, Sevim Beyza; Baran, Yusuf |
52 | 2010 | The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells | Baran, Yusuf ; Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur |
53 | 2015 | Sphingosine-1-phosphate receptor 2/GQ/Phospholıpase C Axis is a novel mechanism to overcome nilotinib resistance in T315I mutation expressing 32DCL3 murine cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
54 | 2014 | Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis | Tezcanlı Kaymaz, Burçin; Selvi, Nur; Adan Gökbulut, Aysun ; Aktan, Çağdaş; Gündüz, Cumhur; Saydam, Güray; Baran, Yusuf ; Kosova, Buket |
55 | 2015 | Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines | Kacı, Necmiye; Kiraz, Yağmur ; Baran, Yusuf |
16 | 2009 | Targeting ceramide metabolism increased sensitivity of Philadelphia positif chronic megacaryoblastic leukemia cells to dasatinib | Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
17 | 2015 | Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
18 | 2010 | Therapeutic potential of targeting sphingolipid signaling pathways in various types of cancers | Baran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde |
19 | 2012 | Zoledronate induces apoptosis via effecting on stat pathway in chronic myeloid leukemia cells | Saydam, Güray; Kiper, Hatice Demet; Tezcanlı, Burçin; Selvi, Nur; Avcı, Çığır Biray; Baran, Yusuf ; Şahin, Fahri |